Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
21.79
-0.05 (-0.23%)
Feb 4, 2026, 11:34 AM CST

SHE:002393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,2281,6391,9891,7931,6521,561
Short-Term Investments
-80.4670.72---
Trading Asset Securities
810.75573.36160.54200.32--
Cash & Short-Term Investments
2,0392,2932,2201,9941,6521,561
Cash Growth
-10.21%3.27%11.37%20.69%5.80%-7.72%
Accounts Receivable
395.36427.03312.51387.99414393.66
Other Receivables
289.133.214.410.877.433.78
Receivables
684.49430.24316.91398.86421.43397.44
Inventory
209.74224.37176.28199.15228.78238.18
Other Current Assets
212.23112.29105.1133.7854.3247.41
Total Current Assets
3,1453,0602,8192,6252,3562,244
Property, Plant & Equipment
977.641,020976.481,0301,1371,088
Long-Term Investments
1,32592.77194.051,4311,5001,485
Goodwill
70.4170.72----
Other Intangible Assets
178.65184.06124.86135.49144.22148.08
Long-Term Deferred Tax Assets
39.4943.839.4733.7116.316.61
Long-Term Deferred Charges
1.080.92----
Other Long-Term Assets
184.11,3131,62735.9837.4950.82
Total Assets
5,9215,7865,7815,2915,1915,022
Accounts Payable
96.95135.8490.36146.3890.49128.3
Accrued Expenses
64.7290.83251.39297.23228.97147.89
Short-Term Debt
2539.7928.639.2928.1419.16
Current Portion of Leases
2.452.840.870.420.4-
Current Income Taxes Payable
40.5211.7214.612.225.794.67
Current Unearned Revenue
11.483414.9430.5411.2916.68
Other Current Liabilities
439.36231.5225.5203.9187.4186.06
Total Current Liabilities
680.47746.53626.27729.98552.47502.76
Long-Term Leases
6.528.383.955.376.2-
Long-Term Unearned Revenue
33.6828.5127.9331.8331.6829.11
Pension & Post-Retirement Benefits
11.151111.3511.2811.3111.59
Long-Term Deferred Tax Liabilities
179.5181.01204.09162.04178.77176.63
Other Long-Term Liabilities
6.5310.113.581.16--
Total Liabilities
917.85985.54877.17941.66780.42720.09
Common Stock
257.62257.9184.28183.99182.45182.45
Additional Paid-In Capital
1,6161,6521,7211,7121,6921,692
Retained Earnings
2,2191,9421,8571,5511,5121,408
Treasury Stock
-97.3-61.05-24.09-21.01--
Comprehensive Income & Other
974.21978.461,165924.041,0251,020
Total Common Equity
4,9704,7704,9034,3494,4114,302
Minority Interest
33.7730.06----
Shareholders' Equity
5,0034,8004,9034,3494,4114,302
Total Liabilities & Equity
5,9215,7865,7815,2915,1915,022
Total Debt
33.9851.0133.4245.0834.7419.16
Net Cash (Debt)
2,0052,2422,1871,9491,6171,542
Net Cash Growth
-7.96%2.51%12.23%20.49%4.86%-7.38%
Net Cash Per Share
7.808.758.467.586.346.39
Filing Date Shares Outstanding
256.18256.27260.86257.59255.44255.44
Total Common Shares Outstanding
256.18256.27260.86257.59255.44255.44
Working Capital
2,4652,3132,1921,8951,8041,742
Book Value Per Share
19.4018.6118.8016.8817.2716.84
Tangible Book Value
4,7214,5154,7794,2144,2664,154
Tangible Book Value Per Share
18.4317.6218.3216.3616.7016.26
Buildings
-989.32930.62950.07941.9933.95
Machinery
-552.53507.9517.78496.86479.2
Construction In Progress
-17.617.0412.79154.5188.83
Source: S&P Global Market Intelligence. Standard template. Financial Sources.